3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Specimen Handling
6
Cytarabine
6
fludarabine
5
Biopsy
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Cyclophosphamide
4
venetoclax
3
decitabine and cedazuridine drug combination
3
Mycophenolic Acid
3
Melphalan
3
Injections
3
Idarubicin
3
CPX-351
3
Busulfan
3
Blood Specimen Collection
3
ruxolitinib
2
nilotinib
2
luspatercept
2
ivosidenib
2
asciminib
2
Thiotepa
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Liposomes
2
Gemtuzumab
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
2C4 antibody
×
30 days
×
Clear all
No trials found.